A complete Series A financial model for Healthcare Biotech startups. Revenue model, unit economics, hiring plan, cash flow projections, and funding scenarios — structured for investor review.
Projection Horizon
5 years (monthly for Years 1-2, annual for Years 3-5)
Model Tabs
8 core tabs
Format
Excel + Google Sheets
Scalability of the revenue model and efficiency of the go-to-market. Series A investors validate that the growth engine is repeatable and unit economics improve with scale.
Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts.
Series A models are reviewed by investment committee analysts. Include a data room version with formula audit trail turned on. Avoid hardcoded numbers in cells — every input should flow from the assumption dashboard.
Three scenarios: upside (125% of plan), base (100%), and downside (70%). Include key assumption levers for each scenario and the capital required in each path.
A Series A Healthcare Biotech financial model should cover 5 years (monthly for Years 1-2, annual for Years 3-5) of projections with these tabs: Executive Summary Model, Revenue Model with Cohorts, Unit Economics Dashboard, Headcount Plan by Department, Departmental P&L, Cash Flow Forecast, Funding Scenarios, Sensitivity Analysis. Scalability of the revenue model and efficiency of the go-to-market. Series A investors validate that the growth engine is repeatable and unit economics improve with scale.
Reimbursement-driven revenue model with payer mix, reimbursement rates, and billing collection efficiency. Model patient volume ramp separately from revenue per patient as payer mix shifts. The key revenue drivers are: Patient volume x reimbursement rate by payer class; Commercial payer revenue (higher reimbursement); Medicare/Medicaid revenue (standardized rates); Enterprise health system contract revenue.
Healthcare Biotech unit economics at the Series A stage should include: Revenue per patient by payer type; Cost to serve per patient (clinical + overhead); Contribution margin per patient at break-even; Patient acquisition cost via provider referral; Prior authorization denial rate and cost impact. Healthcare models must show revenue cycle efficiency separately from clinical cost. Investors want to see AR days trend, denial rate trend, and payer mix shift over time — not just blended revenue per patient.
Series A models are reviewed by investment committee analysts. Include a data room version with formula audit trail turned on. Avoid hardcoded numbers in cells — every input should flow from the assumption dashboard. Start with the smallest unit of your business (one customer, one transaction, one seat) and build up from there. Every assumption should have a source or benchmark you can defend in an investor meeting.
Three scenarios: upside (125% of plan), base (100%), and downside (70%). Include key assumption levers for each scenario and the capital required in each path.
Get the Healthcare Biotech Series A financial model as a pre-built Excel and Google Sheets template. Assumptions dashboard, revenue model, unit economics, and cash flow — ready to customize.
Includes Excel file, Google Sheets version, and model documentation guide